Providers can discuss the risks and benefits of being screened now or at a later date, including the consideration of the patient’s personal and family history, other risk factors, and timing of the last screening test

Vaccinations have declined during the COVID-19 pandemic, but an American Cancer Society aims to boost HPV immunization for cancer prevention with a renewed campaign.

New research illustrates the importance of providing education and training to pediatric and family medicine providers regarding human papillomavirus (HPV) vaccines.

In the rapidly changing landscape surrounding the COVID-19 pandemic, it is imperative that health care providers remain abreast of current recommendations from reliable sources.

When a patient or provider makes the decision to quit smoking, it is critical to address not only the benefits of smoking cessation but the challenges that lie ahead.

Officials with the FDA have approved a supplemental application for Merck's Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) that expands the approved use of the vaccine to include individuals aged 27 to 45 years.

Health care professionals were more likely to be vaccinated when their workplace promoted or required vaccines.

An analysis of 19 clinical studies shows that an association exists between omega-3 polyunsaturated fatty acid treatment and a reduced severity of anxiety symptoms.

More adolescents are starting and completing the human papillomavirus (HPV) series of immunizations, but some forms of cancers caused by the virus are rising.

The latest recommendation from the United States Preventive Services Task Force said cervical cancer screening depends on a woman’s age and other factors.